| 1:11-cv-00402 | Somaxon Pharmaceuticals Inc. v. Actavis Elizabeth LLC et al | May 9, 2011 |
| 1:11-cv-00476 | Somaxon Pharmaceuticals Inc. v. Par Pharmaceutical Inc. et al | May 26, 2011 |
| 1:11-cv-00537 | Somaxon Pharmaceuticals Inc. et al v. Zydus Pharmaceuticals (USA) Inc. et al | Jun 16, 2011 |
| 1:11-cv-00571 | Somaxon Pharmaceuticals Inc. v. Mylan Inc. et al | Jun 28, 2011 |
| 2:12-cv-06643 | Classen Immunotherapies Inc v. Somaxon Pharmaceuticals | Aug 1, 2012 |
| 1:19-cv-01569 | Currax Pharmaceuticals LLC v. Zydus Pharmaceuticals (USA) Inc. et al | Aug 23, 2019 |
| 1:20-cv-01064 | Currax Pharmaceuticals LLC v. MSN Laboratories Private Limited et al. | Aug 13, 2020 |
| 3:21-cv-20765 | CURRAX PHARMACEUTICALS LLC v. AUROLIFE PHARMA LLC | Dec 30, 2021 |
| 1:22-cv-00154 | Acerta Pharma B.V. et al v. Alembic Pharmaceuticals Limited | Feb 2, 2022 |
| 1:22-cv-00155 | Acerta Pharma B.V. et al v. Natco Pharma Limited et al | Feb 2, 2022 |
| 1:22-cv-00162 | Acerta Pharma B.V. et al v. Cipla Limited et al | Feb 4, 2022 |
| 1:22-cv-00163 | Acerta Pharma B.V. et al v. MSN Pharmaceuticals Inc., et al. | Feb 4, 2022 |
| 1:22-cv-00164 | Acerta Pharma B.V. et al v. Sandoz Inc. | Feb 4, 2022 |
| 1:18-cv-00581 | Acerta Pharma B.V. et al v. Pharmacyclics LLC et al | Apr 18, 2018 |
| IPR2023-00478 | Sandoz Inc. v. Acerta Pharma B.V. et al. | Feb 3, 2023 |
| 1:23-cv-00548 | Acerta Pharma B.V. et al v. Alembic Pharmaceuticals Limited et al | May 19, 2023 |
| 1:23-cv-03937 | CURRAX PHARMACEUTICALS LLC v. AJANTA PHARMA LIMITED et al | Jul 24, 2023 |
